ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
7
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
5,651
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Klinische Implikationen der PORTEC-3-Studie zur Behandlung des Hochrisikoendometriumkarzinoms
Author(s):
Till Waltar
,
Simone Marnitz
Publication date:
2020
Journal:
Strahlentherapie und Onkologie
Read this article at
ScienceOpen
Publisher
Further versions
open (via crossref license)
Powered by
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
HTWK Leipzig / OA-HVerlag
Author and article information
Journal
DOI::
10.1007/s00066-020-01592-1
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
5,651
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
Authors:
RA Nout
,
VTHBM Smit
,
H Putter
Second Cancers in Patients Treated With Surgery and Radiation Therapy for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
Authors:
L.M. Wiltink
,
R.A. Nout
,
M. Fiocco
…
LBA63 - Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy
Authors:
CL Creutzberg
,
A Leon-Castillo
,
SM De Boer
…
See all similar
Cited by
1
PORTEC-3-Studie für Endometriumkarzinome mit hohem Risiko: Auswirkungen der molekularen Klassifizierung auf die Prognose und den Nutzen einer adjuvanten Therapie
Authors:
Simone Marnitz
,
Birgid Schömig-Markiefka
See all cited by